CliffBio
small molecule

ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE

ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE

Loss of exclusivity—loss of exclusivity
CompanyTaro Pharmaceutical Industries →See this company's full patent-cliff portfolio

Drug detail

Brand nameENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE
Active ingredientENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE
Strength5MG;12.5MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalSeptember 2001
Marketing statusRX

More from Taro Pharmaceutical Industries

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.